Evaxion Biotech Company

Evaxion Biotech is devoted to the discovery and development of vaccines against cancer and infectious diseases.

Last Funding Type: Post-IPO Equity
Funding Status: IPO
Headquarters: Copenhagen, Hovedstaden, Denmark
Founded Date: 2008-01-01
Last Funding Date: 2022-09-06
Total Funding: 400000000
Technology: Biotechnology
Employee Number: 51-100
Estimated Revenue: $1M to $10M
Investors Number: 2.0
Industry: Immunotherapy Development